Century Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Century Therapeutics, Inc. annual/quarterly Interest Expense history and growth rate from Q3 2020 to Q2 2023.
  • Century Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2023 was $136K, a 58.8% decline year-over-year.
  • Century Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2023 was $913K, a 29.1% decline year-over-year.
  • Century Therapeutics, Inc. annual Interest Expense for 2023 was $540K, a 46.9% decline from 2022.
  • Century Therapeutics, Inc. annual Interest Expense for 2022 was $1.02M, a 20.2% decline from 2021.
  • Century Therapeutics, Inc. annual Interest Expense for 2021 was $1.28M, a 235% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $913K $136K -$194K -58.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.11M $404K +$90K +28.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.02M $0 -$321K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.34M $373K +$51K +15.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.29M $330K +$12K +3.77% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.28M $314K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.28M $321K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $322K +$263K +446% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $318K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $314K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $59K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.